🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07000461
Recruiting Observational

Transcranial Doppler as a Predictor of Postoperative Cognitive Dysfunction Following Cardiopulmonary Bypass

NCT07000461 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-04-17
Last updated
2026-02-17

Condition(s) studied

Postoperative Cognitive DysfunctionDelirium, Postoperative

Investigational drug(s) / intervention(s)

Transcranial Doppler measurement of the middle cerebral artery

Transcranial Doppler measurement of the middle cerebral artery: Transcranial Doppler examination was performed using a low-frequency (2-3.5 MHz) sector/cardiac probe through the transtemporal acoustic window. Middle cerebral artery (MCA) flow was identified in color Doppler mode at a depth of 3-7 cm with flow directed toward the probe. Pulsed-wave Doppler was applied, and peak systolic and end-diastolic velocities were recorded as the average of three measurements.

Study summary

Neurological dysfunction either transient or permanent is a major cause of morbidity and mortality after cardiopulmonary bypass, and cognitive dysfunction is more frequent in cardiac surgery than in non-cardiac procedures. Variations in cerebral blood flow and oxygen extraction are considered key contributing factors. Although pulsatile flow during bypass has shown benefits for renal function and recovery, its effects on postoperative neurological dysfunction and delirium remain unclear due to limited research. This study aims to evaluate the impact of pulsatile versus non-pulsatile cardiopulmonary bypass flow on POCD in adult CABG patients by measuring middle cerebral artery (MCA) flow using transcranial Doppler.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged 18-70 * Patients scheduled for isolated elective cardiopulmonary bypass surgery Exclusion Criteria: * Patients with carotid stenosis ≥50% * Emergency patients or those with a history of reoperation * Patients with a history of cerebrovascular events * Patients who do not provide consent * Patients with temporal window failure * Patients with an ejection fraction (EF) \<40% * Patients with a Mini-Mental State Examination (MMSE) score \<23 * Patients who require mechanical ventilation for more than 24 hours or those who are reintubated

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bakirkoy Dr. Sadi Konuk Research and Training Hospital Istanbul Turkey (Türkiye) Recruiting

More Bakirkoy Dr. Sadi Konuk Research and Training Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07000461 on ClinicalTrials.gov ↗ ← All trials in Turkey